Revenue
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2023
2024
2025
2026
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 · Mar 31 | 2020 · Jan 31 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $5,000 | $2,500 | $0 | — | — | — | $2.7M | $2.4M | $1.9M | $2.3M | $3.2M | $3.2M | $2.6M | $2.2M | $1.9M | $1.7M |
| Gross profit | — | — | — | — | — | — | — | — | $2.5M | $2.1M | $1.4M | $2.1M | $2.1M | $1.6M | $1.4M | $969,000 | $143,000 |
| Gross margin | — | — | — | — | — | — | — | — | 102.53% | 113.99% | 62.65% | 66.05% | 66.05% | 63.95% | 62.96% | 51.93% | 8.58% |
| Research & development | $1.6M | $1.3M | $0 | — | — | — | — | $314,000 | $345,000 | $375,000 | $329,000 | $310.0M | $310,000 | $356,000 | $444,000 | $605,000 | $734,000 |
| Operating expenses | $4.4M | $2.9M | $310,088 | $8.5M | $309,171 | $326,000 | $246,000 | — | $172,000 | $1.9M | $1.6M | $1.7M | $1.7M | $1.6M | $2.1M | $2.5M | $3.3M |
| Operating income | −$4.4M | −$2.9M | −$307,588 | −$8.5M | −$309,171 | −$326,000 | — | — | $751 | $181 | — | — | — | — | — | — | — |
| Operating margin | — | −58,387.30% | −12,303.52% | — | — | — | — | — | 0.03% | 0.01% | — | — | — | — | — | — | — |
| EBITDA | −$4.0M | −$2.9M | −$298,202 | −$8.5M | — | — | — | — | $56,751 | $7,181 | — | — | — | — | — | — | — |
| EBITDA margin | — | −58,238.12% | −11,928.08% | — | — | — | — | — | 2.36% | 0.39% | — | — | — | — | — | — | — |
| Net income | −$4.0M | −$2.9M | −$298,202 | −$8.5M | −$287,171 | −$326,000 | $5.5M | — | $334,000 | −$202,000 | −$509,000 | $33,000 | −$318,000 | −$318,000 | −$1.0M | −$1.8M | −$3.2M |
| Net profit margin | — | −58,026.42% | −11,928.08% | — | — | — | — | — | 13.87% | −10.87% | −22.29% | 1.04% | −10.00% | −12.35% | −46.06% | −97.11% | −191.18% |
| Basic EPSper basic share | -$0.22 | -$0.32 | -$0.29 | -$1.43 | -$0.30 | -$0.58 | $11.50 | — | $1.00 | -$0.50 | -$1.00 | $0.00 | $0.00 | -$1.00 | -$2.50 | -$4.00 | -$7.50 |
| Diluted EPSper diluted share | -$0.22 | -$0.32 | -$0.29 | -$1.43 | -$0.27 | -$0.50 | $11.50 | — | $0.50 | -$0.50 | -$1.00 | $0.00 | $0.00 | -$1.00 | -$2.50 | -$4.00 | -$7.50 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
Alteral Therapeutics ApS | 5.3M |
GK Partners ApS | 3.26M |
AC Nordic ApS | 3.12M |
ABCHill Holding ApS | 916.33K |
Rouf Henrik | 15.97K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Aug 20, 2025Form 4 | Rouf HenrikChief Executive Officer | SellCommon Stock | 26.7K | $2.00 | $53.3K | 16.0K |
| Aug 8, 2025Form 4 | GK Partners ApSTenPercentOwner | SellCommon Stock | 23.3K | $2.00 | $46.6K | 3.26M |
| Jul 30, 2025Form 4 | AC Nordic ApSTenPercentOwner | BuyCommon Stock, par value $0.001 per share | 100.0K | $1.90 | $190.0K | 3.12M |
| Jul 3, 2025Form 4 | AC Nordic ApSTenPercentOwner | BuyCommon Stock, par value $0.001 per share | 42.5K | $1.90 | $80.8K | 3.02M |
| Jul 2, 2025Form 4 | AC Nordic ApSTenPercentOwner | BuyCommon Stock, par value $0.001 per share | 25.0K | $1.90 | $47.5K | 2.98M |